These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3971426)

  • 21. [Epidemiologic study by interview on carcinoma in situ of the cervix uteri].
    Fujimoto I; Nemoto H; Fukuda K; Masubuchi K
    Gan No Rinsho; 1985 Aug; 31(10):1297-302. PubMed ID: 4057564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoma in situ and cervical carcinoma during the use of oral contraceptives].
    Wunder G
    Fortschr Med; 1973 Sep; 91(27):1082-4. PubMed ID: 4746761
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiology of cervical carcinoma in Brunei Darussalam. Analysis of data on 27,208 women screened with cytologic examinations.
    Affandi MZ; Dun T; Mantuano V; Sidhu R; Lumplugh C; Telisinghe PU
    Acta Cytol; 1993; 37(2):175-80. PubMed ID: 8465637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teenage cervical carcinoma in situ.
    Wallace DL; Slankard JE
    Obstet Gynecol; 1973 May; 41(5):697-700. PubMed ID: 4696983
    [No Abstract]   [Full Text] [Related]  

  • 25. [Epidemiology and prophylaxis of cervix carcinoma].
    Held E
    Ther Ggw; 1980 Jan; 119(1):44-57. PubMed ID: 7394737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of risk factors in CA CX at Government Medical College and Hospital, Aurangabad (Marathwada).
    Rao BN; Shewalkar BK
    Indian J Cancer; 2000; 37(2-3):74-8. PubMed ID: 11876613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cytologic screening on the detection of cervical carcinoma.
    Yajima A; Mori T; Sato S; Wakisaka T; Suzuki M
    Obstet Gynecol; 1982 May; 59(5):565-8. PubMed ID: 7070726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer in a female-to-male trans-sexual.
    Driák D; Samudovský M
    Eur J Cancer; 2004 Jul; 40(11):1795. PubMed ID: 15251171
    [No Abstract]   [Full Text] [Related]  

  • 30. [The occurrence of cervix uteri cancer in young women].
    Crane-Elders AB; Bouma J
    Ned Tijdschr Geneeskd; 1982 Nov; 126(46):2096-9. PubMed ID: 7177215
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience in screening for cervical cancer in rural areas of Barsi Tehsil (Maharashtra).
    Nene BM; Jayant K; Malvi SG; Dale PS; Deshpande R
    Indian J Cancer; 1994 Mar; 31(1):34-40. PubMed ID: 8063335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of patients with carcinoma of the uterine cervix treated at Kent General Hospital from 1961-1971.
    Ryan FM
    Del Med J; 1973 Aug; 45(8):221-4. PubMed ID: 4728204
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and outcome of dysplasia of cervix in self-selected population of Thailand.
    Srivannaboon S; Bhamarapravati N
    J Med Assoc Thai; 1974 Jul; 57(7):351-6. PubMed ID: 4853761
    [No Abstract]   [Full Text] [Related]  

  • 36. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Walton report and its subsequent impact on cervical cancer screening programs in Canada.
    Worth AJ
    Obstet Gynecol; 1984 Feb; 63(2):135-9. PubMed ID: 6694805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk group oriented early detection of cervical cancer? (author's transl)].
    Flach W; Pockrandt H
    Arch Geschwulstforsch; 1981; 51(8):673-7. PubMed ID: 7340713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 40. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.